Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients.

Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients. Haematologica. 2019 Sep 26;: Authors: Frerichs KA, Bosman PWC, van Velzen JF, Fraaij PLA, Koopmans MPG, Rimmelzwaan GF, Nijhof IS, Bloem AC, Mutis T, Zweegman S, van de Donk NWCJ Abstract PMID: 31558675 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31558675?dopt=Abstract

Source: Haematologica - September 25, 2019 Category: Hematology Authors: Frerichs KA, Bosman PWC, van Velzen JF, Fraaij PLA, Koopmans MPG, Rimmelzwaan GF, Nijhof IS, Bloem AC, Mutis T, Zweegman S, van de Donk NWCJ Tags: Haematologica Source Type: research

More News: Hematology | Myeloma | Vaccines